Navigation Links
Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
Date:9/11/2008

Growth in the laboratory automation industry is expected from increased demand for complex and higher throughput systems in biotechnology and pharmaceutical markets. The advent of advanced and sophisticated technologies with enhanced focus on rapid, accurate and timely results is contributing to the higher demand for laboratory automation systems.

San Jose, California (PRWEB) September 11, 2008 -- Automation is an important tool in the development and improvement of laboratory operations. Laboratory automation systems are finding extensive application in numerous lab processes, ranging from simple capping and decapping of sample bottles to complex high throughput screening of test samples. Rising utilization of laboratory automation products as a routine tool in high throughput screening and drug discovery applications, as well as molecular testing market are expected to push up sales for the industry.

http://www.strategyr.com/Laboratory_Automation_Industry_Market_Report.asp [Laboratory automation industry], although in early growth stage, is expected to offer enormous growth opportunities for manufacturers, driven by increased demand from pharmaceutical and biotechnology markets. The need to develop new and effective drugs in shorter time periods is pushing companies to acquire highly automated laboratories. Scientists and researchers have whole genomes of potential drug targets at the disposal for testing, against an array of drug candidates, which requires high throughput automation. Automation has also become common in agriculture, food, and environment analytical labs.

Advent of new and advanced technologies with increased focus on providing accurate, rapid and timely output has contributed to the accelerated development and launch of innovative lab automation systems into t
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
3. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
4. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
5. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
6. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery
7. Onyx Pharmaceuticals to Present at Biotechnology Industry Organization Investor Forum
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
10. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
11. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
Breaking Biology News(10 mins):Newly discovered mechanism allows cells to change state 2Tropical birds waited for land crossing between North and South America: UBC study 2U S Debut 3A Holistic Health And Beauty From The Rainforest New Book Reveals Closely Guarded Malaysian Health and Beauty Secrets Introducing the Wo 51638 1U S Debut 3A Holistic Health And Beauty From The Rainforest New Book Reveals Closely Guarded Malaysian Health and Beauty Secrets Introducing the Wo 51638 2U S Debut 3A Holistic Health And Beauty From The Rainforest New Book Reveals Closely Guarded Malaysian Health and Beauty Secrets Introducing the Wo 51638 3CardioNet Terminates Merger With Biotel 51633 1Santaris Pharma Interim Report for the Period 1 January to 30 June 2009 13023 1Santaris Pharma Interim Report for the Period 1 January to 30 June 2009 13023 2Santaris Pharma Interim Report for the Period 1 January to 30 June 2009 13023 3Santaris Pharma Interim Report for the Period 1 January to 30 June 2009 13023 4Santaris Pharma Interim Report for the Period 1 January to 30 June 2009 13023 5Santaris Pharma Interim Report for the Period 1 January to 30 June 2009 13023 6Santaris Pharma Interim Report for the Period 1 January to 30 June 2009 13023 7Santaris Pharma Interim Report for the Period 1 January to 30 June 2009 13023 8Santaris Pharma Interim Report for the Period 1 January to 30 June 2009 13023 9